How severe is CVE-2025-32363?

CVE-2025-32363 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2025-32363 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (51st percentile), an estimate of the probability of exploitation in the next 30 days.

How do I fix CVE-2025-32363?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.

Does CVE-2025-32363 have an EU (EUVD) identifier?

Yes. CVE-2025-32363 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-14897.

When was CVE-2025-32363 published?

CVE-2025-32363 was published on 2025-05-14 and last updated on 2026-06-17.

CVE-2025-32363

CVE-2025-32363 is a critical-severity vulnerability with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-94.

Key facts

Severity: Critical (CVSS 3.x base score 9.8)
EPSS exploit prediction: 1% (51st percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2025-14897
Weakness: CWE-94
Published: 2025-05-14
Last modified: 2026-06-17

Description

mediDOK before 2.5.18.43 allows remote attackers to achieve remote code execution on a target system via deserialization of untrusted data.

Frequently asked questions

What is CVE-2025-32363?: mediDOK before 2.5.18.43 allows remote attackers to achieve remote code execution on a target system via deserialization of untrusted data.
How severe is CVE-2025-32363?: CVE-2025-32363 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2025-32363 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (51st percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2025-32363?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
Does CVE-2025-32363 have an EU (EUVD) identifier?: Yes. CVE-2025-32363 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-14897.
When was CVE-2025-32363 published?: CVE-2025-32363 was published on 2025-05-14 and last updated on 2026-06-17.

References

Other CWE-94 (Code Injection) vulnerabilities

CVE-2026-57624 — Critical (CVSS 10.0): Unauthenticated Remote Code Execution (RCE) in Blocksy Companion Pro <= 2.1.46 versions.
CVE-2026-10134 — Critical (CVSS 10.0): IBM Langflow OSS 1.0.0 through 1.9.3 allows an attacker to read every secret available to the Langflow process, read…
CVE-2026-53576 — Critical (CVSS 10.0): Kestra is an open-source, event-driven orchestration platform. Prior to 1.0.45 and 1.3.21, the authentication filter…
CVE-2026-10561 — Critical (CVSS 10.0): IBM Langflow OSS 1.0.0 through 1.9.3 has an vulnerability due to an improper isolation of Python execution combined…
CVE-2026-25470 — Critical (CVSS 10.0): Improper Control of Generation of Code ('Code Injection') vulnerability in ACPT ACPT (Pro) - Custom Post Types Plugin…
CVE-2026-48836 — Critical (CVSS 10.0): Unauthenticated Remote Code Execution (RCE) in Easy Invoice <= 2.1.19 versions.

Browse all CWE-94 (Code Injection) vulnerabilities →